Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 2492107, 16 pages
http://dx.doi.org/10.1155/2016/2492107
Research Article

Nigella sativa Relieves the Altered Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats Fed with a High-Fat Diet

1Biochemistry Department, Faculty of Science, Alexandria University, Alexandria 21511, Egypt
2Biochemistry Department, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt

Received 29 March 2016; Revised 20 June 2016; Accepted 30 June 2016

Academic Editor: Tullia Maraldi

Copyright © 2016 Mahmoud Balbaa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ventura-Sobrevilla, V. D. Boone-Villa, C. N. Aguilar et al., “Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice,” Proceedings of the Western Pharmacology Society, vol. 54, pp. 5–9, 2011. View at Google Scholar
  2. T. Tuomi, “Type 1 and type 2 diabetes: what do they have in common?” Diabetes, vol. 54, no. 2, pp. S40–S45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Sachin, K. O. Shreesh, and V. Divya, “Characterization of streptozotocin induced diabetes mellitus in Swiss albino mice,” Global Journal of Pharmacology, vol. 3, no. 2, pp. 81–84, 2009. View at Google Scholar
  4. A. Zorzano, W. Wilkinson, N. Kotliar et al., “Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations,” The Journal of Biological Chemistry, vol. 264, no. 21, pp. 12358–12363, 1989. View at Google Scholar · View at Scopus
  5. A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri, “Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease,” Endocrine Reviews, vol. 30, no. 6, pp. 586–623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Charpentier, F. Fleury, M. Kabir, L. Vaur, and S. Halimi, “Improved glycemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients,” Diabetic Medicine, vol. 18, no. 10, pp. 828–834, 2001. View at Google Scholar
  7. T. A. Gaziano, G. Galea, and K. S. Reddy, “Scaling up interventions for chronic disease prevention: the evidence,” The Lancet, vol. 370, no. 9603, pp. 1939–1946, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. C. Woo, S. Y. Loo, V. Gee et al., “Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway,” Biochemical Pharmacology, vol. 82, no. 5, pp. 464–475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A.-M. M. Fouda, M.-H. Y. Daba, G. M. Dahab, and O. A. Sharaf El-Din, “Thymoquinone ameliorates renal oxidative damage and proliferative response induced by mercuric chloride in rats,” Basic and Clinical Pharmacology and Toxicology, vol. 103, no. 2, pp. 109–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. O. A. Badary, M. F. Abd-Ellah, M. A. El-Mahdy, S. A. Salama, and F. M. Hamada, “Anticlastogenic activity of thymoquinone against benzo(a)pyrene in mice,” Food and Chemical Toxicology, vol. 45, no. 1, pp. 88–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Gali-Muhtasib, A. Roessner, and R. Schneider-Stock, “Thymoquinone: a promising anti-cancer drug from natural sources,” The International Journal of Biochemistry and Cell Biology, vol. 38, no. 8, pp. 1249–1253, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Hosseinzadeh and S. Parvardeh, “Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice,” Phytomedicine, vol. 11, no. 1, pp. 56–64, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Meddah, R. Ducroc, M. El Abbes Faouzi et al., “Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats,” Journal of Ethnopharmacology, vol. 121, no. 3, pp. 419–424, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. R. Mahmoud, H. S. El-Abhar, and S. Saleh, “The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice,” Journal of Ethnopharmacology, vol. 79, no. 1, pp. 1–11, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. M. K. Swamy and B. K. H. Tan, “Cytotoxic and immunopotentiating effects of ethanolic extract of Nigella sativa L. seeds,” Journal of Ethnopharmacology, vol. 70, no. 1, pp. 1–7, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Srinivasan, P. S. Patole, C. L. Kaul, and P. Ramarao, “Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 26, no. 5, pp. 327–333, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. A. H. Rahman and S. Venkatraman, “Evaluation of anti-diabetic activity of Picrorhiza scrophulariiflora Pennell in high fat fed diet with streptozotocin induced type II diabetic rats,” International Journal of Pharmaceutical Sciences and Research, vol. 2, no. 7, pp. 1829–1835, 2011. View at Google Scholar
  19. D. Kianifard, R. A. Sadrkhanlou, and S. Hasanzadeh, “The histological, histomorphometrical and histochemical changes of testicular tissue in the metformin treated and untreated streptozotocin-induced adult diabetic rats,” Veterinary Research Forum, vol. 2, no. 1, pp. 13–24, 2011. View at Google Scholar
  20. G. Blum, A. Gazit, and A. Levitzki, “Substrate competitive inhibitors of IGF-1 receptor kinase,” Biochemistry, vol. 39, no. 51, pp. 15705–15712, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. L. de Barros Leite Albuquerque, C. A. Dal Belo, M. G. dos Santos, P. S. Lopes, M. Gerenutti, and Y. Oshima-Franco, “Assessment of cytotoxicity, fetotoxicity, and teratogenicity of Plathymenia reticulata benth barks aqueous extract,” BioMed Research International, vol. 2013, Article ID 128594, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. Altan, M. Kanter, S. Donmez, M. E. Kartal, and S. Buyukbas, “Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats,” Acta Histochemica, vol. 109, no. 4, pp. 304–314, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Trinder, “Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor,” Annals of Clinical Biochemistry, vol. 6, no. 1, pp. 24–33, 1969. View at Publisher · View at Google Scholar
  24. B. T. Doumas, D. D. Bayse, R. J. Carter, T. Peters Jr., and R. Schaffer, “A candidate reference method for determination of total protein in serum. I. Development and validation,” Clinical Chemistry, vol. 27, no. 10, pp. 1642–1650, 1981. View at Google Scholar · View at Scopus
  25. P. C. Kao, R. L. Taylor, and F. J. Service, “Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma,” The Journal of Clinical Endocrinology and Metabolism, vol. 78, no. 5, pp. 1048–1051, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Salama, W. Ibrahim, T. El-Nimr, M. A. Abd El-, and E. Tousson, “Effect of myrrh extract (Mirazid®) on experimentally diabetic rats,” Pharmacologia, vol. 5, no. 4, pp. 135–142, 2014. View at Publisher · View at Google Scholar
  27. H. M. Flegg, “An investigation of the determination of serum cholesterol by an enzymatic method,” Annals of Clinical Biochemistry, vol. 10, no. 1–6, pp. 79–84, 1973. View at Google Scholar
  28. G. Bucolo and H. David, “Quantitative determination of serum triglycerides by the use of enzymes,” Clinical Chemistry, vol. 19, no. 5, pp. 476–482, 1973. View at Google Scholar · View at Scopus
  29. A. M. Gotto Jr., “Lipoprotein metabolism and the etiology of hyperlipidemia,” Hospital Practice, vol. 23, no. 1, pp. 4–13, 1988. View at Publisher · View at Google Scholar · View at Scopus
  30. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  31. A. Hakim, A. Mittal, and S. Das, “Study of the antihyperlipidemic, anioxidative and anti-atherogenic activity of Aegle marmelos Linn. in rabbit receiving high fat diet,” Asian Journal of Pharmaceutical and Clinical Research, vol. 5, no. 4, pp. 69–72, 2012. View at Google Scholar
  32. A. Łukaszewicz-Hussain, J. Moniuszko-Jakoniuk, and J. Rogalska, “Assessment of lipid peroxidation in rat tissues in subacute chlorfenvinphos administration,” Polish Journal of Environmental Studies, vol. 16, no. 2, pp. 233–236, 2007. View at Google Scholar · View at Scopus
  33. A. L. Tappel and H. Zalkin, “Inhibition of lipide peroxidation in mitochondria by vitamin E,” Archives of Biochemistry and Biophysics, vol. 80, no. 2, pp. 333–336, 1959. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Menaka, A. Ramesh, B. Thomas, and N. Kumari, “Estimation of nitric oxide as an inflammatory marker in periodontitis,” Journal of Indian Society of Periodontology, vol. 13, no. 2, pp. 75–78, 2009. View at Publisher · View at Google Scholar
  35. P. O. Okonkwo and Z. S. C. Okoye, “Comparative effects of antidiabetic drug, metformin and deferoxamine, on serum lipids, serum ferritin and endocrine indicators of diabetes mellitus complications in sreptozotocin diabetic rats,” International Journal of Biochemistry Research & Review, vol. 4, no. 6, pp. 536–549, 2014. View at Publisher · View at Google Scholar
  36. M. I. Saad, M. A. Kamel, M. Y. Hanafi, M. H. Helmy, and R. Shehata, “Effect of sitagliptin and glimepiride on glucose homeostasis and cAMP levels in peripheral tissues of HFD/STZ diabetic rats,” American Journal of Biomedical Research, vol. 2, no. 3, pp. 52–60, 2014. View at Publisher · View at Google Scholar
  37. O. Paulina, A. Rasaki, and A. Veronica, “Effect of raw and cooked ginger (Zingiber officinale) extracts on serum insulin in normal and diabetic rats,” International Journal of Clinical Nutrition, vol. 2, no. 4, pp. 69–73, 2014. View at Google Scholar
  38. L. H. Storlien, D. A. Pan, A. D. Kriketos et al., “Skeletal muscle membrane lipids and insulin resistance,” Lipids, vol. 31, no. 1, pp. S261–S265, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Özel, J. F. Youngren, J. K. Kim, I. D. Goldfine, C. K. Sung, and J. H. Youn, “The development of insulin resistance with high fat feeding in rats does not involve either decreased insulin receptor tyrosine kinase activity or membrane glycoprotein PC-1,” Biochemical and Molecular Medicine, vol. 59, no. 2, pp. 174–181, 1996. View at Publisher · View at Google Scholar · View at Scopus
  40. T. J. Chahil and H. N. Ginsberg, “Diabetic dyslipidemia,” Endocrinology and Metabolism Clinics of North America, vol. 35, no. 3, pp. 491–510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. D. Mooradian, “Dyslipidemia in type 2 diabetes mellitus,” Nature Clinical Practice Endocrinology & Metabolism, vol. 5, no. 3, pp. 150–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. K. N. Frayn, “Adipose tissue and the insulin resistance syndrome,” Proceedings of the Nutrition Society, vol. 60, no. 3, pp. 375–380, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. A. D. Mooradian, M. J. Haas, K. R. Wehmeier, and N. C. W. Wong, “Obesity-related changes in high-density lipoprotein metabolism,” Obesity, vol. 16, no. 6, pp. 1152–1160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Gidado, D. A. Ameh, S. E. Atawodi, and S. Ibrahim, “Hypoglycaemic activity of Nauclea latifolia sm. (Rubiaceae) in experimental animals,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 5, no. 2, pp. 201–208, 2008. View at Google Scholar · View at Scopus
  45. E. Shafrir, “Diabetes in animals: contribution to the understanding of diabetes by study of its etiopathology in animal models,” in Diabetes Mellitus, D. Porte, R. S. Sherwin, and A. Baron, Eds., pp. 231–255, McGraw-Hill, New York, NY, USA, 2003. View at Google Scholar
  46. O. E. Yakubu, E. Ojogbane, O. F. C. Nwodo, V. O. Nwaneri-Chidozie, and M. N. Ugwu, “Study of lipid profile and lipid peroxide in diabetes mellitus treated with Vitex donianaethanol leaf extract,” European Journal of Experimental Biology, vol. 3, no. 3, pp. 624–629, 2013. View at Google Scholar
  47. M. Kaleem, D. Kirmani, M. Asif, Q. Ahmed, and B. Bano, “Biochemical effects of Nigella sativa L seeds in diabetic rats,” Indian Journal of Experimental Biology, vol. 44, no. 9, pp. 745–748, 2006. View at Google Scholar · View at Scopus
  48. Y. Kocyigit, Y. Atamer, and E. Uysal, “The effect of dietary supplementation of Nigella sativa L. on serum lipid profile in rats,” Saudi Medical Journal, vol. 30, no. 7, pp. 893–896, 2009. View at Google Scholar · View at Scopus
  49. A. Virkamäki, K. Ueki, and C. R. Kahn, “Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance,” The Journal of Clinical Investigation, vol. 103, no. 7, pp. 931–943, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Højlund, “Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance,” Danish Medical Journal, vol. 61, no. 7, Article ID B4890, 2014. View at Google Scholar · View at Scopus
  51. S. J. Robins, “Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?” Current Opinion in Lipidology, vol. 14, no. 6, pp. 575–583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Anai, M. Funaki, T. Ogihara et al., “Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats,” Diabetes, vol. 47, no. 1, pp. 13–23, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. D. E. Moller, “New drug targets for type 2 diabetes and the metabolic syndrome,” Nature, vol. 414, no. 6865, pp. 821–827, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Garg, R. Kiran, and D. D. Bansal, “High sucrose low magnesium diet modulates the expression of PI3K and ERK2 in different tissues of weanling rats,” American Journal of Biomedical Sciences, vol. 3, no. 1, pp. 11–22, 2011. View at Publisher · View at Google Scholar
  55. G. Boden, “Obesity and free fatty acids,” Endocrinology and Metabolism Clinics of North America, vol. 37, no. 3, pp. 635–646, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. H.-D. Yuan and S.-H. Chung, “Protective effects of fermented ginseng on streptozotocin-induced pancreatic β-cell damage through inhibition of NF-κB,” International Journal of Molecular Medicine, vol. 25, no. 1, pp. 53–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Federici, R. Menghini, A. Mauriello et al., “Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells,” Circulation, vol. 106, no. 4, pp. 466–472, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Menghini, S. Menini, R. Amoruso et al., “Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice,” Gastroenterology, vol. 136, no. 2, pp. 663–672.e4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Rui, V. Aguirre, J. K. Kim et al., “Insulin/IGF-1 and TNF-α stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways,” The Journal of Clinical Investigation, vol. 107, no. 2, pp. 181–189, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. N. T. Niture, A. A. Ansari, and S. R. Naik, “Anti-hyperglycemic activity of Rutin in streptozotocin-induced diabetic rats: An effect mediated through cytokines, antioxidants and lipid biomarkers,” Indian Journal of Experimental Biology, vol. 52, no. 7, pp. 720–727, 2014. View at Google Scholar · View at Scopus
  61. A. M. Saud, “Serum levels of tumor necrosis factor alpha and interleukin-12 in some Iraqi diabetic patients type I,” International Journal of Current Microbiology and Applied Science, vol. 3, no. 4, pp. 260–268, 2014. View at Google Scholar
  62. M. Bartoli, F. Lamoke, S. Shaw, D. Gutsaeva, and B. Baban, “Modulation of cytokine trans-signaling by microRNA-21 (miR-21)-mediated regulation of TACE/ADAM17 in the diabetic retina,” Investigative Ophthalmology and Visual Science, vol. 55, no. 13, p. 1030, 2014. View at Google Scholar
  63. R. Nahta, L. X. H. Yuan, B. Zhang, R. Kobayashi, and F. J. Esteva, “Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells,” Cancer Research, vol. 65, no. 23, pp. 11118–11128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. P. M. Le, A. Benhaddou-Andaloussi, A. Elimadi, A. Settaf, Y. Cherrah, and P. S. Haddad, “The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat,” Journal of Ethnopharmacology, vol. 94, no. 2-3, pp. 251–259, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Houstis, E. D. Rosen, and E. S. Lander, “Reactive oxygen species have a causal role in multiple forms of insulin resistance,” Nature, vol. 440, no. 7086, pp. 944–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Song, W. Jia, Y. Yao et al., “Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes,” Clinical Science, vol. 112, no. 12, pp. 599–606, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. Q. Wang, R. Somwar, P. J. Bilan et al., “Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts,” Molecular and Cellular Biology, vol. 19, no. 6, pp. 4008–4018, 1999. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Mamta and K. Preeti, “Interacting effect of co-administration of Urtica dioica leaf extract with two oral antidiabetic agents (glimepiride and metformin) in streptozotocin and DNA induced diabetic rats,” International Journal of Universal Pharmacy and Biosciences, vol. 2, no. 6, pp. 326–335, 2013. View at Google Scholar
  69. T. Poonam, G. P. Prakash, and L. V. Kumar, “Interaction of Momordica Charantia with metformin in diabetic rats,” American Journal of Pharmacology and Toxicology, vol. 8, no. 3, pp. 102–106, 2013. View at Publisher · View at Google Scholar · View at Scopus